ROCKWELL MEDICAL, INC.
RMTIRockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
Drugs in Pipeline
5
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
SFP
End Stage Renal Disease
Soluble Ferric Pyrophosphate (SFP)
Renal Failure Chronic Requiring Hemodialysis
Soluble Ferric Pyrophosphate in liquid bicarbonate
End Stage Renal Disease
Soluble Ferric Pyrophosphate
Kidney Failure
Triferic
End Stage Renal Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
SFP | Phase 3 | End Stage Renal Disease | - | - |
Soluble Ferric Pyrophosphate (SFP) | Phase 3 | Renal Failure Chronic Requiring Hemodialysis | - | - |
Soluble Ferric Pyrophosphate in liquid bicarbonate | Phase 2 | End Stage Renal Disease | - | - |
Soluble Ferric Pyrophosphate | Phase 2 | Kidney Failure | - | - |
Triferic | Phase 2 | End Stage Renal Disease | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in ROCKWELL MEDICAL, INC.'s drug pipeline?→
CatalystAlert tracks 5 drug candidates in ROCKWELL MEDICAL, INC.'s (RMTI) pipeline across Phase 3, Phase 2. Its lead program is SFP (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is ROCKWELL MEDICAL, INC.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for ROCKWELL MEDICAL, INC. (RMTI) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track RMTI biotech catalysts?→
Add RMTI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ROCKWELL MEDICAL, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.